ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Changhong Miao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3406-8877; OpenAlex author ID A5100382083. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Di Zhou · 1 shared paper, 2025 · strength 0.28
- Paper Neutrophil Extracellular Traps Promote Pancreatic Cancer Progression via the STING Pathway. DOI 10.1155/grp/4950214 ↗
Mengdi Qu · 1 shared paper, 2025 · strength 0.28
- Paper Neutrophil Extracellular Traps Promote Pancreatic Cancer Progression via the STING Pathway. DOI 10.1155/grp/4950214 ↗
Sisi Chen · 1 shared paper, 2017 · strength 0.08
- Paper Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor. DOI 10.1016/j.ejphar.2016.12.017 ↗
You Li · 1 shared paper, 2017 · strength 0.08
- Paper Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor. DOI 10.1016/j.ejphar.2016.12.017 ↗
Xiangyuan Chen · 1 shared paper, 2017 · strength 0.08
- Paper Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor. DOI 10.1016/j.ejphar.2016.12.017 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.